# NIAID-VRC- Rapid Manufacturing Response

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2022 · $9,822,408

## Abstract

The Vaccine Research Center (VRC) mission and scope includes rapidly moving clinical candidates from the research bench through development and GMP manufacturing to the clinic. The VRC is exploring a wide range of initiatives, including but not limited to new technologies which would decrease the time between candidate discovery and first-in-human clinical trials. These initiatives will allow VRC and NIAID to quickly assess clinical stage products for safety and efficacy and to expedite the production and supply of investigational products to the field during public health emergencies.

## Key facts

- **NIH application ID:** 10722383
- **Project number:** 75N91019D00024-0-759102200002-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** DAVID LINDSAY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $9,822,408
- **Award type:** —
- **Project period:** 2022-09-16 → 2027-09-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10722383

## Citation

> US National Institutes of Health, RePORTER application 10722383, NIAID-VRC- Rapid Manufacturing Response (75N91019D00024-0-759102200002-1). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10722383. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*